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Abstract: 
Breast cancer is a malignant neoplasm originating from breast tissue, most commonly from the inner lining of milk ducts or the 
lobules that supply the ducts with milk. ILCs and IDCs vary from each other with respect to various histological, biological and 
clinical features. Remarkably, ductal tumors tending to form glandular structures, whereas lobular tumors are less cohesive and 
tends to invade in single file. The high degree of similarity in the prognoses of IDC and ILC makes it beneficial to develop a 
differential diagnostic protocol to classify the two conditions. The main goal of the study is to construct the genetic regulatory 
network from the microarray data using biological knowledge and constraint-based inferences, in order to explore the potential 
significant gene regulatory networks that can differentiate IDC and ILC and thereby understand the complex interactions that are 
influenced by the genetic networks. Out of the 54676 genes present on the GPL570 platform- 29 genes exhibited 4 fold up 
regulation in case of IDC and 22 in the case of ILC. The ductal and lobular tumors displayed a striking difference in the expression 
of genes associated with cell adhesion, protein folding, and protein phosphorylation and invasion. Construction of separate gene 
regulation networks for IDC and ILC on the basis of gene expression altercation can be utilized in understanding the distinction in 
the possible mechanism that underlies the pathological differences between the two, which can be exploited in identifying 
diagnostic or therapeutic targets. 
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Background: 
Cancer is an abnormal growth of cells caused by multiple 
changes in gene expression leading to dysregulated balance of 
cell proliferation and cell death and ultimately evolving into a 
population of cells that can invade tissues and metastasize to 
distant sites, causing significant morbidity and, if untreated, 
death of the host.  
 
Breast cancer is a malignant neoplasm originating from breast 
tissue, most commonly from the inner lining of milk ducts or BIOINFORMATION  open access 
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the lobules that supply the ducts with milk [1]. Highly complex 
and heterogeneous nature of the disorder makes it exceedingly 
difficult to analyze and understand the disease in a 
comprehensive manner, in spite of strenuous efforts. Breast 
cancer is the second leading cause of cancer deaths in women 
today (after lung cancer) and is the most common cancer among 
women, excluding nonmelanoma skin cancers. According to the 
American Cancer Society, about 1.3 million women will be 
diagnosed with breast cancer annually worldwide and about 
465,000 will die from the disease [2]. Breast MRI, biopsy, 
ultrasound, CT scan, Mammography, lymph node biopsy are 
the most common protocols employed in the diagnosis of breast 
cancer. 
 
Out of ~ 20 pathological types that have been defined - invasive 
ductal (IDCs) and invasive lobular carcinomas (ILCs) are the 
most common malignancies of the breast. Invasive ductal and 
lobular breast carcinomas account for 80% and 15% of all 
invasive breast tumors, respectively [3]. Invasive (or 
infiltrating) ductal carcinoma (IDC) starts in a milk passage 
(duct) of the breast, breaks through the wall of the duct, and 
grows into the fatty tissue of the breast. At this point, it may be 
able to metastasize to other parts of the body through the 
lymphatic system and bloodstream, whereas Invasive lobular 
carcinoma (ILC) starts in the milk-producing glands (lobules) 
and subsequently it can metastasize to other parts of the body.  
 
ILCs and IDCs vary from each other with respect to various 
histological, biological and clinical features. Remarkably, ductal 
tumors tending to form glandular structures, whereas lobular 
tumors are less cohesive and tends to invade in single file. This 
feature has been associated with the frequent inactivation of the 
E-cadherin gene (CDH1) [4]. ILCs are predominantly estrogen 
receptor (ER), and progesterone receptor (PR) positive, and thus 
presumably more homogeneous than IDCs. Their pathological 
grade is generally lower than that of IDCs and they exhibit 
lower proliferation index [5]. ILCs are less sensitive to 
chemotherapy  [6] and are more prone to form bone, 
gastrointestinal, peritoneal and ovarian metastases than IDCs 
[7]. They also have lower vascular endothelial growth factor 
expression  [8]. Despite these differences, ILCs show similar 
prognoses as IDCs [9], and the diagnosis and treatment of ILCs 
and IDCs is similar. 
 
A differential diagnosis is a systematic method used to identify 
unknowns. It is essentially a process of elimination used 
medical professionals to diagnose the specific disease in a 
patient. The high degree of similarity in the prognoses of IDC 
and ILC makes it beneficial to develop a differential diagnostic 
protocol to classify the two conditions. Therefore, it is crucial to 
gain deep insight into the molecular differences that distinguish 
the two pathological types in order to attempt differential 
diagnosis and to tailor specific treatment methods. 
 
A few microarray studies have been performed to identify the 
differential gene expression between IDCs and ILCs, but they 
still utilize the traditional unsupervised clustering methods to 
realize the potential molecular variation between the two 
pathological types. Manual analysis of tumors based on 
expression array analyses can identify a gene set that 
distinguishes these two subtypes of breast tumors. Microarray 
data can reveal information pertaining to not only gene 
expression but also regarding genetic networks of a particular 
biological process. 
 
Networks are pervasive in biology [10]. These network data 
extend and compliment a great deal of other information 
available in the biomedical sciences. Although various datasets 
can appear quite different in quality and quantity, they all are 
reflections of the same underlying biological system and its 
responses [11]. Thus a network elucidating the molecular basis 
and interaction between the components can yield a possible 
insight for differentiating pathological types. 
 
The main goal of the study is to construct the genetic regulatory 
network from the microarray data using biological knowledge 
and constraint-based inferences, in order to explore the 
potential significant gene regulatory networks that can 
differentiate IDC and ILC and thereby understand the complex 
interactions that are influenced by the genetic networks. 
 
Methodology: 
Dataset Collection 
A comprehensive search of all eligible studies on differential 
gene expression of IDC and ILC (as on April 2010) was made by 
searching the electronic literature (PubMed database) for 
relevant published reports and by manual searching of 
reference lists of articles on this topic. Only human studies in 
the English language were included in the analysis. Based on 
the literature survey GEO record GDS2635 of the Platform 
GPL570. 5 diseased and 10 control samples for each of IDC & 
ILC were taken for analysis.  
 
Gene expression analysis 
A meta analysis of the chosen datasets was performed using the 
Gene Spring Gx 7.3 software. GeneSpring GX provides 
powerful, accessible statistical tools for fast visualization and 
analysis of expression and genomic structural variation data. 
Designed specifically for the needs of biologists, GeneSpring 
GX offers an interactive desktop computing environment that 
promotes investigation and enables understanding of 
microarray data within a biological context [12].  
 
The datasets were normalized to standardize microarray data to 
enable differentiation between real (biological) variations in 
gene expression levels and variations due to the measurement 
process. The genes were filtered based on fold changes. The 
fold changes in gene expression levels between the disease 
samples control samples to check for the differential expression.  
Genes which were differentially up regulated by 4 fold were 
filtered out and their gene ontology was identified. 
 
Gene Network Construction 
Two gene networks to study the molecular differences between 
IDC and ILC were constructed using BisoGenet plugin [13] for 
Cytoscape was used for generation of biological networks. The 
Networks were generated taking as input an initial list of 
identifiers of genes filtered out on basis of fold change.  
 
Network Analysis 
The network obtained from the BisoGenet Server is analyzed 
using the plugin Network Analyzer. For every node in a 
network, NetworkAnalyzer computes its degree, its clustering 
coefficient, the number of self-loops, and a variety of other BIOINFORMATION  open access 
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parameters [14].The Overrepresentation or underrepresentation 
of GO categories was assessed using The Biological Networks 
Gene Ontology tool (BiNGO) 
 
Discussion: 
Preliminary Analysis 
The gene expression profiling of Invasive Ductal carcinoma and 
Invasive Lobular Carcinoma dataset containing 5 samples each 
was used to find the up regulated and down-regulated genes. 
First the up regulated and down-regulated genes were obtained 
by comparing Invasive Ductal carcinoma samples to control 
samples at a fold change of 4.  
 
The gene expression data pertaining to both invasive ductal 
carcinoma and invasive lobular carcinoma was subjected to 
meta analysis. The genes which were upregulated by 4 fold 
were chosen. Out of the 54676 genes present on the gpl570 
platform- 29 genes exhibited 4 fold up regulation in case of IDC 
and 22 in the case of ILC. Table 1 & 2 (see supplementary 
material) illustrate the list of the filtered genes in each of the 
two pathological states. These upregulated genes were 
analyzed systematically based on their ontology.  
 
Accurate and precise diagnosis and subsequent treatment of 
IDC and ILC remain elusive and difficult owing to high degree 
of similarity in the prognosis of the two pathological types [9]. 
Gene expression profiling technique is widely in the 
measurement of the expression of thousands of genes at once 
and thereby creates a global picture of a biological 
phenomenon. The technology is employed in order to obtain a 
clear insight on how the expression of every individual gene is 
altered in a particular physiological state. Ideology was to look 
for subtle differences in gene expression may be responsible for 
the phenotypic differences between them. 
 
The Gene expression profiling datasets available from 
previously concluded studies were used to find the list of gene 
which is significantly differentially expressed genes between 
the Invasive Ductal Carcinoma and Invasive Lobular 
Carcinoma. Detailed analysis of tumors was used to identify a 
gene set that distinguishes these two subtypes of breast tumors. 
 
As indicated by the highly similar prognosis and physiological 
manifestation of the two pathological subtypes - It is observed 
that both the types of tumor exhibit a very similar expression 
level for numerous genes. 
 
 
Figure 1: The top ranked gene dense cliques for A. IDC & B. 
ILC 
Construction of Gene Regulatory Networks 
Gene regulatory networks of the gene set compiled on the basis 
of expression level altercations can yield a heuristic insight into 
the molecular basis of the prognosis and thereby can be utilized 
to discover specific diagnostic and tailored disease targeting. 
The two complex gene networks that emerged as a resultant of 
the interaction between upregulated genes was broken down 
into smaller sub networks using mcode module of cytoscape. 
The top ranked gene dense cliques were found and subjected to 
further analysis by mapping each node to be corresponding 
ontology. The top ranked gene dense cliques are depicted in 
(Figure 1). The Tables 3 & 4 (see supplementary material) 
show the list of genes which constituents the top ranked dense 
clique along with their respective ontology. 
 
Analyzing Gene Clusters 
The gene clusters obtained contain only 3 genes in common - 
CDK1, HDAC and ESR. Cyclin dependent kinase 1 is a key 
player in cell cycle regulation. Cdk1 substrates frequently 
contain multiple phosphorylation sites that are clustered in 
regions of intrinsic disorder, and their exact position in the 
protein is often poorly conserved in evolution, indicating that 
precise positioning of phosphorylation is not required for 
regulation of the substrate [15]. Cdk1 interacts with nine 
different cyclins throughout the cell cycle. The interaction with 
cyclins is important for activation of its kinase activity [16]. 
CDK1 and ESR are key components of estrogen responsive 
protein efp controls cell cycle and breast tumors growth. 
Histone deacetylases (HDAC) are involved in removing the 
acetyl groups (O=C-CH3) from an ε-N-acetyl lysine amino acid 
on a histone. The fact that acetylation is a key component in the 
regulation of gene expression has stimulated the study of 
HDACs in relation to the aberrant gene expression often 
observed in cancer. Although no direct alteration in the 
expression of HDACs has yet been demonstrated in human 
oncogenesis, it is now known that HDACs associate with a 
number of well characterized cellular oncogenes and tumour-
suppressor genes [e.g. Mad and retinoblastoma protein (Rb)], 
leading to an aberrant recruitment of HDAC activity, which in 
turn results in changes in gene expression [17, 18]. 
 
A notable observation was that ductal and lobular tumors 
displayed a striking difference in the expression of genes 
associated with cell adhesion (PCDH9, IBSP, COL11A1, and 
CTNNB1), motility (S100P), apoptosis (HDAC1, IKBKB and 
BUB1), protein folding (CPB1, RAB26), extracellular matrix 
(COL11A1, PRMT1), and protein phosphorylation and invasion 
(ESRRA, SMAD3, HDAC2, STRN), This suggests that they may 
achieve invasive growth through separate mechanisms and 
evolve via distinct genetic pathways. 
 
The ILC genes are differentially expressed compared to IDC 
genes and are involved in other biological processes such as 
nucleosome disassembly- HIST1H2AD, SMARCE1, intracellular 
signaling pathway - GSK3B, GRB2, CALM3, DNA repair and 
negative regulation of DNA binding - SUMO1, TOP2A, UBC, 
BRCA1 . 
 
HIST1H2AD gene codes for Histone H2A type 1-D which is a 
core component of nucleosome involved in compacting DNA 
into chromatin and limiting DNA accessibility to the cellular 
machineries which require DNA as a template [19, 20]. BIOINFORMATION  open access 
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SMARCE1 is involved in alteration of DNA-nucleosome 
topology, Involved in transcriptional activation and repression 
of select genes by chromatin remodeling [21]. The gene 
regulatory network constructed can be used as a hypothetical 
molecular framework to develop a diagnostic marker specific to 
each of the two pathological states of interest. The validity of 
the hypothesized biomarkers can be validated by employing 
available in vitro techniques. 
 
Conclusion: 
To sum up, we have utilized the Construction of separate gene 
regulation networks for IDC and ILC on the basis of gene 
expression altercation reveals clear distinction in the 
mechanism that underlies the pathological differences between 
the two. The molecular level understanding of the pathological 
manifestations can be exploited i n  f u t u r e  t o  f i n d  u n i q u e  b i o  
markers for diagnosis and to identify ideal therapeutic drug 
targets. 
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Supplementary material:  
 
Table 1: Gene list: upregulated genes in Invasive Ductal Carcinoma at Fold change 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Gene list: upregulated genes in Invasive Lobular Carcinoma at Fold change 4 
  S. No.  Gene Symbol  Gene Ontology 
1.  PRKRA  Immune response and induction of apoptosis 
2.  SGCG  Cytoskeleton organization and muscle organ development 
3.  CRTC3  Regulation of transcription 
4.  NCOA3  Positive regulation of transcription, DNA-dependent 
5.  SIX1 Cell  division 
6.  HSPA12A Protein  Folding 
7.  NEK2 Cell  division 
8.  SIX1 Epithelial  cell  differentiation 
9.  RAB26 Protein  transport 
10.  HOXB7  Multicellular organismal development 
11.  COL10A1 Skeletal  system  development 
12.  SPTBN1 Actin  filament  capping 
13.  COCH  Sensory perception of sound 
14.  NOX4  Cell aging, cell morphogenesis, negative regulation of cell 
proliferation 
15.  TMEM55A  Degradation Of Phosphatidylinositol 4,5-Bisphosphate 
16.  TOP2A Chromosome  segregation 
17.  FBN1  Heart development and kidney development 
18.  LRRC15 Unknown  Function 
19.  COL11A1  Extracellular matrix organization 
 
 
 
 
 
S. No.  Gene Symbol  Gene Ontology 
1.  SPATA2 Cell  differentiation 
2.  S100P  Endothelial cell migration 
3.  LOC145837 Hypothetical 
4.  FAM40B DNA  binding 
5.  ZNF670  Regulation of transcription, DNA-dependent 
6.  MRPL35 Translation 
7.  DTNA Signal  transduction  and synaptic transmission 
8.  C16orf54 Transmembrane  Protein 
9.  TNNT1  Muscle filament sliding and skeletal muscle contraction 
10.  POLQc  DNA repair and DNA replication 
11.  CPB1 Proteolysis 
12.  C20orf114  Innate Immune Response 
13.  GBP4 Guanylate  Binding 
14.  PCDH9 Cell  adhesion 
15.  INTS10 snRNA  processing 
16.  FBN1  Heart development and kidney development 
17.  KIF20A Cytokinesis 
18.  TRIM59 DNA  Binding 
19.  HIST1H2AD Nucleosome  assembly 
20.  BUB1  Apoptosis and cell division 
21.  IBSP Cell  adhesion 
22.  HMMR  cell motility 
23.  SMEK1  May regulate the activity of PPP4C at centrosomal microtubule 
organizing centers.  
24.  ASPM  Cell cycle and cell division 
25.  COL11A1 Cell  adhesion 
26.  TOP2A Chromosome  segregation BIOINFORMATION  open access 
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Table 3: Gene list: Dense clique ranked 1 from Cytoscape plugin MCODE for Invasive Ductal Carcinoma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Gene list: Dense clique ranked 1 from Cytoscape plugin MCODE for Invasive Lobular Carcinoma 
S. No.  Gene Symbol  Gene Ontology 
1  IKBKG  Induction of apoptosis 
2 DHX9  Gene  expression 
3  NR1H2  Regulation of transcription from RNA polymerase II promoter and gene 
expression 
4  MAPK1  Signal transduction and cell cycle 
5  GRB2  Cell-cell signalling and cell differentiation 
6  CDK1  Cell aging and cell division 
7 IKBKB  Anti-apoptosis 
8  ESRRA  Gene expression and regulation cell proliferation 
9  SUMO1  DNA repair and negative regulation of DNA binding 
10  PPARG  Negative regulation of transcription from RNA polymerase II promoter and 
signal transduction 
11 GSK3B  Intracellular  signaling  pathway 
12 TOP2A  DNA  replication 
13  EIF2AK2  Negative regulation of cell proliferation 
14  CCND1  Regulation of cell cycle 
15 SMARCE1  Nucleosome  disassembly 
16  SMAD3  Negative regulation of cell proliferation 
17  PRMT1  Cell surface receptor linked signaling pathway 
18  NR0B2  Regulation of transcription, DNA-dependent 
19 STAT1  Signal  transduction 
20 EP300  Cell  cycle 
21  CREBBP  Signal transduction and cell proliferation 
22  UBC  DNA damage response, signal transduction by p53 class mediator resulting in 
cell cycle arrest 
23  JUN  Regulation of cell cycle and aging 
24  BRCA1  DNA repair and cell cycle 
25 ESR1  Signal  transduction 
26 NCOA1  − 
27 HDAC1  Anti-apoptosis 
28  CTNNB1  Negative regulation of cell proliferation, apoptosis and cell adhesion 
 
S. No.  Gene Symbol  Gene Ontology 
1 FAM40A  DNA  Binding 
2  HDAC2  Negative regulation of cell cycle and positive regulation of cell proliferation 
3 CTTNBP2NL  − 
4 FAM40B  DNA  binding 
5  ESR2  Signal transduction, cell-cell signaling and gene expression 
6  CDK1  Cell division, positive regulation of gene expression 
7 MOBKL3  Transport 
8 CALM2  Intracellular  signaling  pathway 
9 CALM3  Intracellular  signaling  pathway 
10  CSNK2A1P  Wnt receptor signaling pathway 
11  STRN  Negative regulation of cell proliferation 
12  CALM1  G-protein coupled receptor protein signaling pathway 
13  CSNK2A1  Signal transduction and Wnt receptor signaling pathway 
14  STRN3  Negative regulation of transcription 